The Roles of Pathogen-Associated Molecular Patterns in Atherosclerosis

Trends in Cardiovascular Medicine

Volumn 18, Issue 2, 2008, Pages 52-56

  Erridge, Clett ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ATORVASTATIN; CERIVASTATIN; ENDOTOXIN; LIGAND; LIPOPOLYSACCHARIDE; OLIVE OIL; RESVERATROL; TOLL LIKE RECEPTOR;

ARTERY WALL; ATHEROGENESIS; ATHEROSCLEROSIS; BACTEREMIA; CARDIOVASCULAR RISK; HUMAN; INFECTION; INFLAMMATION; INFLAMMATORY DISEASE; INSULIN RESISTANCE; LIPID DIET; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ATHEROSCLEROSIS; BACTERIAL INFECTIONS; HUMANS; INFLAMMATION; RECEPTORS, PATTERN RECOGNITION; TOLL-LIKE RECEPTORS;

EID: 39549103221     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2007.12.003     Document Type: Review

References (42)

1. Brun P., Castagliuolo I., Di Leo V., et al. Increased intestinal permeability in obese mice: new evidences in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 292 (2006) G518-G525
2. Cani P.D., Amar J., Iglesias M.A., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56 (2007) 1761-1772
3. Cao F., Castrillo A., Tontonoz P., et al. Chlamydia pneumoniae-induced macrophage foam cell formation is mediated by Toll-like receptor 2. Infect Immun 75 (2007) 753-759
4. Castrillo A., Joseph S.B., Vaidya S.A., et al. Crosstalk between LXR and Toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol Cell 12 (2003) 805-816
5. Creely S.J., McTernan P.G., Kusminski C.M., et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 292 (2007) E740-E747
6. Dunzendorfer S., Lee H.K., and Tobias P.S. Flow-dependent regulation of endothelial Toll-like receptor 2 expression through inhibition of SP1 activity. Circ Res 95 (2004) 684-691
7. Edfeldt K., Swedenborg J., Hansson G.K., and Yan Z. Expression of Toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 105 (2002) 1158-1160
8. Erridge C., Spickett C.M., and Webb D.J. Non-enterobacterial endotoxins stimulate human coronary artery but not venous endothelial cell activation via Toll-like receptor 2. Cardiovasc Res 73 (2007) 181-189
9. Erridge C., Webb D.J., and Spickett C.M. Toll-like receptor 4 signalling is neither sufficient nor required for oxidised phospholipid mediated induction of interleukin-8 expression. Atherosclerosis 193 (2007) 77-85
10. Erridge C., Attina T., Spickett C.M., and Webb D.J. A high-fat meal induces low-grade endotoxaemia: evidence of a novel mechanism of post-prandial inflammation. Am J Clin Nutr 86 (2007) 1286-1292
11. Espinola-Klein C., Rupprecht H.J., Blankenberg S., et al. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 105 (2002) 15-21
12. Gibson G.R. Dietary modulation of the human gut microflora using prebiotics. Br J Nutr 80 (1998) S209-S212
13. Griffiths E.A., Duffy L.C., Schanbacher F.L., et al. In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice. Dig Dis Sci 49 (2004) 579-589
14. Juvonen J., Juvonen T., Laurila A., et al. Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms. J Vasc Surg 25 (1997) 499-505
15. Kiechl S., Egger G., Mayr M., et al. Chronic infections and the risk of carotid atherosclerosis prospective results from a large population study. Circulation 103 (2001) 1064-1070
16. Kim F., Pham M., Luttrell I., et al. Toll like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ Res 100 (2007) 1589-1596
17. Lalla E., Lamster I.B., Hofmann M.A., et al. Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 23 (2003) 1405-1411
18. Laman J.D., Schoneveld A.H., Moll F.L., et al. Significance of peptidoglycan, a proinflammatory bacterial antigen in atherosclerotic arteries and its association with vulnerable plaques. Am J Cardiol 90 (2002) 119-123
19. Lee J.Y., Zhao L., Youn H.S., et al. Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J Biol Chem 279 (2004) 16971-16979
20. Lehr H.A., Sagban T.A., Ihling C., et al. Immunopathogenesis of atherosclerosis: endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet. Circulation 104 (2001) 914-920
21. Lehtonen L., Eerola E., Oksman P., and Toivanen P. Muramic acid in peripheral blood leukocytes of healthy human subjects. J Infect Dis 171 (1995) 1060-1064
22. Leite M.S., Pacheco P., Gomes R.N., et al. Mechanisms of increased survival after lipopolysaccharide-induced endotoxic shock in mice consuming olive oil-enriched diet. Shock 23 (2005) 173-178
23. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
24. Liu C., and Waters D.D. Chlamydia pneumoniae and atherosclerosis: from Koch's postulates to clinical trials. Prog Cardiovasc Dis 47 (2005) 230-239
25. Liu X., Ukai T., Yumoto H., et al. Toll-like receptor 2 plays a critical role in the progression of atherosclerosis that is independent of dietary lipids. Atherosclerosis (2007) 10.1016/j.atherosclerosis.2007.03.025
26. May A.E., Redecke V., Grüner S., et al. Recruitment of Chlamydia pneumoniae-infected macrophages to the carotid artery wall in noninfected, nonatherosclerotic mice. Arterioscler Thromb Vasc Biol 23 (2003) 789-794
27. Michelson K.S., Wong M.H., Shah P.K., et al. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci U S A 101 (2004) 10679-10684
28. Miller Y.I., Chang M.K., Binder C.J., et al. Oxidized low density lipoprotein and innate immune receptors. Curr Opin Lipidol 14 (2003) 437-445
29. Mullick A.E., Tobias P.S., and Curtiss L.K. Modulation of atherosclerosis in mice by Toll-like receptor 2. J Clin Invest 115 (2005) 3149-3156
30. Nanji A.A., Khettry U., and Sadrzadeh S.M. Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver disease. Proc Soc Exp Biol Med 205 (1994) 243-247
31. Netea M.G., Kullberg B.J., Demacker P.N.M., et al. Native LDL potentiate TNF-α and IL-8 production by human mononuclear cells. J Lipid Res 43 (2002) 1065-1071
32. Ott S.J., El Mokhtari N.E., Musfeldt M., et al. Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation 113 (2006) 929-937
33. Poggi M., Bastelica D., Gual P., et al. C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet. Diabetologia 50 (2007) 1267-1276
34. Rice J.B., Stoll L.L., Li W.G., et al. Low-level endotoxin induces potent inflammatory activation of human blood vessels: inhibition by statins. Arterioscler Thromb Vasc Biol 23 (2003) 1576-1582
35. Schoneveld A.H., Oude Nijhuis M.M., van Middelaar B., et al. Toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development. Cardiovasc Res 66 (2005) 162-169
36. Shi H., Kokoeva M.V., Inouye K., et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116 (2006) 3015-3025
37. Takeda K., and Akira S. TLR signaling pathways. Semin Immunol 16 (2004) 3-9
38. Tsan M.F., and Gao B. Pathogen-associated molecular pattern contamination as putative endogenous ligands of Toll-like receptors. J Endotoxin Res 13 (2007) 6-14
39. Tsukumo D.M., Carvalho-Filho M.A., Carvalheira J.B., et al. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 56 (2007) 1986-1998
40. Wagner H. Endogenous TLR ligands and autoimmunity. Adv Immunol 91 (2006) 159-173
41. Wiedermann C.I., Kiechl S., Dunzendorfer S., et al. Association of endotoxaemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. J Am Coll Cardiol 34 (1999) 1975-1981
42. Youn H.S., Lee J.Y., Fitzgerald K.A., et al. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol, molecular targets are TBK1 and RIP1 in TRIF complex. J Immunol 175 (2005) 3339-3346